Sleep Apnea Syndrome, Obstructive
14
5
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (14)
Bruxism Induced by Obstructive Sleep Apnoea.
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
Sleep Medicine Education in Dental Schools and Residency Programs in Italian Universities
Treatment Failure of Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea Syndrome (OSA): A Trial Comparing Polysomnography and the Sunrise Device to Drive Treatment-Adjustment Decisions.
Empagliflozin and CPAP in Adults With Heart Failure and Obstructive Sleep Apnea.
Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea
A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment
Pilot Study of Negative Pressure Neck Therapy (NPNT)
Actigraphy, Wearable EEG Band and Smartphone for Sleep Staging
Personalised Treatment for OSA
The SNORE-trial: Analysis of Alterations in Sleep Stages Following Anesthesia and Their Relation to the Severity of Obstructive Sleep Apnea in the First 3 Nights After Surgery
Ocular Parameters in Patients With Sleep Apnea
Sunrise® a New Medical Device to Diagnose Sleep Apnea Syndrome